Does angiotensin I-converting enzyme inhibitor therapy have an antiproliferative effect on the blood-forming bone marrow?

Warning

This publication doesn't include Institute of Computer Science. It includes Faculty of Medicine. Official publication website can be found on muni.cz.

Authors	VAŠKŮ Anna SOUČEK Miroslav ZNOJIL Vladimír ŘIHÁČEK Ivan CÍDL Karel STŘELCOVÁ Lenka VÁCHA Jiří
Year of publication	1998
Type	Article in Periodical
Magazine / Source	Experimental Hematology
MU Faculty or unit	Faculty of Medicine
Citation
Field	Oncology and hematology
Keywords	ACEI; RBC
Description	One year ACE inhibitor therapy in 11 patients with essential hypertension was found to cause a decrease in red blood cell counts , together with an increased corpuscular volume in these erythrocytes. Thus, IACE therapy could influence local RAS system in blood-forming bone marrow.
Related projects:	Molecular pathophysiology of selected multigenic related to civilization diseases Polymorphisms of Genes Coding for Angiotensinogen and Angiotensin I Convertase in Essential Hypertension